| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.915 | 0.004 | 0.943 | Analgesic | 0.943 0.004 DBMET00324 0.886 0.005 DBMET00343 0.823 0.005 DBMET00966 0.921 0.004 DBMET00957 0.272 0.164 DBMET00954 0.916 0.004 DBMET00956 | DBMET00324 | |
| 0.652 | 0.009 | 0.769 | Spasmolytic | 0.67 0.008 DBMET00324 0.603 0.013 DBMET00343 0.769 0.005 DBMET00966 0.622 0.011 DBMET00957 0.344 0.054 DBMET00954 0.509 0.022 DBMET00956 | DBMET00966 | |
| 0.598 | 0.004 | 0.708 | Sigma receptor agonist | 0.611 0.004 DBMET00324 0.303 0.038 DBMET00343 0.373 0.026 DBMET00966 0.293 0.04 DBMET00957 0.708 0.003 DBMET00954 0.27 0.045 DBMET00956 | DBMET00954 | |
| 0.56 | 0.024 | 0.75 | Cholesterol antagonist | 0.58 0.021 DBMET00324 0.495 0.033 DBMET00343 0.75 0.005 DBMET00966 0.519 0.03 DBMET00957 0.333 0.072 DBMET00954 0.537 0.027 DBMET00956 | DBMET00966 | |
| 0.531 | 0.004 | 0.65 | Analgesic, opioid | 0.65 0.003 DBMET00324 0.42 0.004 DBMET00343 0.328 0.005 DBMET00966 0.55 0.004 DBMET00957 0.106 0.028 DBMET00954 0.57 0.004 DBMET00956 | DBMET00324 | |
| 0.51 | 0.004 | 0.559 | 5 Hydroxytryptamine uptake inhibitor | 0.553 0.004 DBMET00324 0.519 0.004 DBMET00343 0.142 0.017 DBMET00966 0.559 0.004 DBMET00957 0.48 0.004 DBMET00954 0.44 0.004 DBMET00956 | DBMET00957 | |
| 0.492 | 0.004 | 0.639 | Opioid antagonist | 0.639 0.003 DBMET00324 0.421 0.004 DBMET00343 0.262 0.007 DBMET00966 0.588 0.004 DBMET00957 0.254 0.008 DBMET00954 0.601 0.004 DBMET00956 | DBMET00324 | |
| 0.48 | 0.005 | 0.543 | Antipruritic | 0.543 0.004 DBMET00324 0.341 0.01 DBMET00343 0.394 0.007 DBMET00966 0.392 0.007 DBMET00957 0.241 0.027 DBMET00954 0.413 0.006 DBMET00956 | DBMET00324 | |
| 0.453 | 0.004 | 0.532 | Adrenaline uptake inhibitor | 0.512 0.003 DBMET00324 0.474 0.003 DBMET00343 0.211 0.005 DBMET00966 0.532 0.003 DBMET00957 0.433 0.004 DBMET00954 0.474 0.003 DBMET00956 | DBMET00957 | |
| 0.44 | 0.004 | 0.604 | Opioid agonist | 0.604 0.003 DBMET00324 0.296 0.004 DBMET00343 0.181 0.005 DBMET00966 0.474 0.004 DBMET00957 0.059 0.03 DBMET00954 0.538 0.004 DBMET00956 | DBMET00324 | |
| 0.413 | 0.004 | 0.475 | Opioid kappa receptor antagonist | 0.475 0.003 DBMET00324 0.393 0.004 DBMET00343 0.245 0.007 DBMET00966 0.448 0.004 DBMET00957 0.353 0.005 DBMET00954 0.453 0.003 DBMET00956 | DBMET00324 | |
| 0.411 | 0.025 | 0.522 | Potassium channel (Voltage-sensitive) blocker | 0.394 0.028 DBMET00324 0.522 0.013 DBMET00343 0.519 0.013 DBMET00957 0.331 0.041 DBMET00956 | DBMET00343 | |
| 0.39 | 0.004 | 0.558 | Opioid mu receptor antagonist | 0.558 0.003 DBMET00324 0.321 0.005 DBMET00343 0.205 0.008 DBMET00966 0.507 0.004 DBMET00957 0.204 0.008 DBMET00954 0.531 0.004 DBMET00956 | DBMET00324 | |
| 0.448 | 0.084 | 0.472 | Caspase 9 stimulant | 0.392 0.116 DBMET00324 0.465 0.075 DBMET00343 0.368 0.132 DBMET00966 0.411 0.104 DBMET00957 0.472 0.072 DBMET00954 0.372 0.129 DBMET00956 | DBMET00954 | |
| 0.392 | 0.029 | 0.531 | HERG channel blocker | 0.399 0.028 DBMET00324 0.512 0.014 DBMET00343 0.531 0.013 DBMET00957 0.355 0.036 DBMET00956 | DBMET00957 | |
| 0.349 | 0.004 | 0.539 | Opioid mu receptor agonist | 0.539 0.003 DBMET00324 0.261 0.004 DBMET00343 0.163 0.006 DBMET00966 0.421 0.004 DBMET00957 0.054 0.026 DBMET00954 0.508 0.003 DBMET00956 | DBMET00324 | |
| 0.374 | 0.034 | 0.453 | Antiamyloidogenic | 0.355 0.038 DBMET00324 0.261 0.066 DBMET00343 0.453 0.021 DBMET00966 0.243 0.074 DBMET00957 0.202 0.098 DBMET00956 | DBMET00966 | |
| 0.355 | 0.025 | 0.503 | Cyclic AMP phosphodiesterase inhibitor | 0.349 0.026 DBMET00324 0.162 0.133 DBMET00343 0.503 0.006 DBMET00966 0.159 0.138 DBMET00957 0.157 0.141 DBMET00956 | DBMET00966 | |
| 0.332 | 0.037 | 0.391 | Potassium channel blocker | 0.3 0.046 DBMET00324 0.391 0.024 DBMET00343 0.372 0.028 DBMET00957 0.17 0.115 DBMET00956 | DBMET00343 | |
| 0.27 | 0.003 | 0.301 | Opioid kappa receptor agonist | 0.301 0.003 DBMET00324 0.237 0.004 DBMET00343 0.201 0.004 DBMET00966 0.268 0.004 DBMET00957 0.094 0.01 DBMET00954 0.277 0.003 DBMET00956 | DBMET00324 | |
| 0.262 | 0.005 | 0.274 | Dopamine uptake inhibitor | 0.274 0.004 DBMET00324 0.213 0.005 DBMET00343 0.224 0.005 DBMET00957 0.124 0.014 DBMET00954 0.174 0.008 DBMET00956 | DBMET00324 | |
| 0.31 | 0.089 | 0.673 | Transcription factor NF kappa B inhibitor | 0.342 0.079 DBMET00324 0.289 0.101 DBMET00343 0.673 0.024 DBMET00966 0.31 0.089 DBMET00957 0.263 0.118 DBMET00954 0.328 0.083 DBMET00956 | DBMET00966 | |
| 0.283 | 0.088 | 0.296 | Caspase 3 stimulant | 0.253 0.109 DBMET00324 0.233 0.128 DBMET00343 0.296 0.08 DBMET00966 0.202 0.167 DBMET00957 | DBMET00966 | |
| 0.219 | 0.027 | 0.219 | Anesthetic local | 0.213 0.029 DBMET00324 0.1 0.083 DBMET00343 0.096 0.087 DBMET00957 | ||
| 0.26 | 0.071 | 0.427 | 5 Hydroxytryptamine uptake stimulant | 0.283 0.054 DBMET00324 0.265 0.067 DBMET00343 0.288 0.051 DBMET00957 0.427 0.01 DBMET00954 0.38 0.018 DBMET00956 | DBMET00954 | |
| 0.2 | 0.014 | 0.21 | Antineoplastic alkaloid | 0.21 0.011 DBMET00324 0.136 0.032 DBMET00343 0.096 0.05 DBMET00966 0.15 0.027 DBMET00957 0.196 0.015 DBMET00956 | DBMET00324 | |
| 0.24 | 0.055 | 0.314 | Anesthetic general | 0.25 0.05 DBMET00324 0.206 0.071 DBMET00343 0.234 0.058 DBMET00966 0.217 0.065 DBMET00957 0.314 0.03 DBMET00954 0.229 0.06 DBMET00956 | DBMET00954 | |
| 0.208 | 0.026 | 0.214 | Arachidonic acid antagonist | 0.214 0.021 DBMET00324 0.15 0.088 DBMET00343 0.156 0.082 DBMET00966 0.161 0.075 DBMET00957 0.193 0.04 DBMET00954 0.177 0.057 DBMET00956 | DBMET00324 | |
| 0.238 | 0.063 | 0.271 | Psychostimulant | 0.253 0.057 DBMET00324 0.257 0.056 DBMET00343 0.262 0.054 DBMET00966 0.271 0.051 DBMET00957 0.194 0.083 DBMET00954 0.175 0.097 DBMET00956 | DBMET00957 | |
| 0.175 | 0.004 | 0.372 | Opioid delta receptor agonist | 0.372 0.004 DBMET00324 0.092 0.005 DBMET00343 0.064 0.009 DBMET00966 0.207 0.004 DBMET00957 0.277 0.004 DBMET00956 | DBMET00324 | |
| 0.273 | 0.105 | 0.361 | Sodium/bile acid cotransporter inhibitor | 0.301 0.078 DBMET00324 0.288 0.091 DBMET00343 0.241 0.138 DBMET00966 0.313 0.068 DBMET00957 0.361 0.033 DBMET00954 0.291 0.088 DBMET00956 | DBMET00954 | |
| 0.181 | 0.014 | 0.268 | Opioid delta receptor antagonist | 0.268 0.005 DBMET00324 0.158 0.018 DBMET00343 0.083 0.035 DBMET00966 0.236 0.007 DBMET00957 0.126 0.024 DBMET00954 0.258 0.005 DBMET00956 | DBMET00324 | |
| 0.17 | 0.013 | 0.222 | Dopamine D1 antagonist | 0.222 0.009 DBMET00324 0.121 0.02 DBMET00343 0.153 0.015 DBMET00957 0.108 0.023 DBMET00956 | DBMET00324 | |
| 0.269 | 0.116 | 0.395 | Vasodilator, coronary | 0.225 0.159 DBMET00324 0.395 0.037 DBMET00966 | DBMET00966 | |
| 0.193 | 0.044 | 0.356 | Melanin inhibitor | 0.196 0.042 DBMET00324 0.148 0.084 DBMET00343 0.356 0.015 DBMET00966 0.15 0.081 DBMET00957 0.175 0.055 DBMET00954 0.182 0.05 DBMET00956 | DBMET00966 | |
| 0.186 | 0.037 | 0.189 | 5 Hydroxytryptamine antagonist | 0.142 0.053 DBMET00324 0.189 0.036 DBMET00343 0.144 0.052 DBMET00957 0.092 0.087 DBMET00956 | DBMET00343 | |
| 0.271 | 0.123 | 0.401 | Calcium channel activator | 0.218 0.188 DBMET00324 0.356 0.046 DBMET00343 0.311 0.081 DBMET00957 0.401 0.024 DBMET00954 0.318 0.074 DBMET00956 | DBMET00954 | |
| 0.16 | 0.016 | 0.19 | Toll-Like receptor 4 antagonist | 0.165 0.014 DBMET00324 0.148 0.022 DBMET00343 0.19 0.008 DBMET00966 0.152 0.02 DBMET00957 0.166 0.014 DBMET00956 | DBMET00966 | |
| 0.163 | 0.02 | 0.163 | Alpha 2a adrenoreceptor antagonist | 0.154 0.021 DBMET00324 0.149 0.022 DBMET00343 0.141 0.024 DBMET00957 0.093 0.04 DBMET00954 0.118 0.03 DBMET00956 | ||
| 0.207 | 0.066 | 0.413 | Non-steroidal antiinflammatory agent | 0.187 0.082 DBMET00324 0.413 0.012 DBMET00966 0.207 0.065 DBMET00954 0.145 0.121 DBMET00956 | DBMET00966 | |
| 0.187 | 0.051 | 0.187 | MAP kinase kinase 5 inhibitor | 0.17 0.086 DBMET00324 | ||
| 0.16 | 0.025 | 0.16 | Alpha 2 adrenoreceptor antagonist | 0.139 0.03 DBMET00324 0.139 0.03 DBMET00343 0.118 0.037 DBMET00957 0.104 0.045 DBMET00954 0.097 0.051 DBMET00956 | ||
| 0.224 | 0.093 | 0.295 | Aldehyde oxidase inhibitor | 0.293 0.068 DBMET00324 0.169 0.124 DBMET00957 0.295 0.068 DBMET00954 0.238 0.087 DBMET00956 | DBMET00954 | |
| 0.155 | 0.03 | 0.159 | Alpha 2c adrenoreceptor antagonist | 0.139 0.038 DBMET00324 0.159 0.028 DBMET00343 0.142 0.036 DBMET00957 0.126 0.045 DBMET00954 0.102 0.064 DBMET00956 | DBMET00343 | |
| 0.127 | 0.008 | 0.168 | Dopamine transporter inhibitor | 0.141 0.007 DBMET00324 0.126 0.008 DBMET00343 0.044 0.038 DBMET00966 0.139 0.007 DBMET00957 0.168 0.005 DBMET00954 0.114 0.009 DBMET00956 | DBMET00954 | |
| 0.164 | 0.047 | 0.164 | Acetylcholinesterase inhibitor | 0.143 0.06 DBMET00324 0.117 0.081 DBMET00343 | ||
| 0.187 | 0.074 | 0.187 | P-glycoprotein inhibitor | 0.155 0.11 DBMET00324 0.156 0.107 DBMET00343 0.168 0.091 DBMET00966 | ||
| 0.15 | 0.038 | 0.202 | Alpha 2b adrenoreceptor antagonist | 0.135 0.047 DBMET00324 0.202 0.023 DBMET00343 0.18 0.029 DBMET00957 0.155 0.037 DBMET00954 0.133 0.049 DBMET00956 | DBMET00343 | |
| 0.203 | 0.096 | 0.259 | RNA-directed DNA polymerase inhibitor | 0.23 0.064 DBMET00324 0.182 0.13 DBMET00343 0.195 0.107 DBMET00966 0.209 0.087 DBMET00957 0.259 0.044 DBMET00956 | DBMET00956 | |
| 0.217 | 0.111 | 0.278 | 5 Hydroxytryptamine 1E antagonist | 0.224 0.104 DBMET00324 0.242 0.083 DBMET00343 0.248 0.077 DBMET00957 0.278 0.047 DBMET00954 0.183 0.15 DBMET00956 | DBMET00954 | |
| 0.179 | 0.077 | 0.394 | Nitric oxide antagonist | 0.195 0.069 DBMET00324 0.171 0.081 DBMET00343 0.394 0.026 DBMET00966 0.184 0.074 DBMET00957 0.201 0.067 DBMET00954 0.194 0.069 DBMET00956 | DBMET00966 | |
| 0.175 | 0.076 | 0.316 | Lipocortins synthesis antagonist | 0.177 0.073 DBMET00324 0.162 0.089 DBMET00343 0.168 0.083 DBMET00966 0.163 0.088 DBMET00957 0.316 0.018 DBMET00954 0.16 0.092 DBMET00956 | DBMET00954 | |
| 0.15 | 0.053 | 0.162 | Pregnane X receptor agonist | 0.162 0.035 DBMET00324 0.138 0.078 DBMET00343 0.15 0.052 DBMET00957 0.141 0.07 DBMET00954 0.152 0.049 DBMET00956 | DBMET00324 | |
| 0.206 | 0.109 | 0.246 | Neuropeptide Y2 antagonist | 0.246 0.06 DBMET00324 0.189 0.14 DBMET00956 | DBMET00324 | |
| 0.142 | 0.047 | 0.176 | Vanilloid 1 agonist | 0.135 0.057 DBMET00324 0.176 0.02 DBMET00343 0.124 0.078 DBMET00966 0.167 0.025 DBMET00957 0.142 0.047 DBMET00954 0.15 0.038 DBMET00956 | DBMET00343 | |
| 0.17 | 0.076 | 0.301 | Tumour necrosis factor antagonist | 0.158 0.091 DBMET00343 0.301 0.018 DBMET00954 | DBMET00954 | |
| 0.152 | 0.059 | 0.209 | Adenylate cyclase stimulant | 0.178 0.028 DBMET00324 0.18 0.025 DBMET00343 0.122 0.12 DBMET00966 0.209 0.01 DBMET00957 0.156 0.053 DBMET00954 0.188 0.02 DBMET00956 | DBMET00957 | |
| 0.167 | 0.075 | 0.295 | ATPase inhibitor | 0.171 0.07 DBMET00324 0.143 0.114 DBMET00343 0.295 0.006 DBMET00966 0.147 0.107 DBMET00957 | DBMET00966 | |
| 0.126 | 0.034 | 0.183 | Prolactin inhibitor | 0.183 0.012 DBMET00324 0.12 0.038 DBMET00343 0.177 0.013 DBMET00957 0.115 0.042 DBMET00954 0.157 0.019 DBMET00956 | DBMET00324 | |
| 0.094 | 0.005 | 0.094 | Ryanodine receptor antagonist | 0.07 0.017 DBMET00324 0.087 0.005 DBMET00343 0.066 0.023 DBMET00957 0.08 0.009 DBMET00954 0.079 0.009 DBMET00956 | ||
| 0.139 | 0.051 | 0.175 | Acetylcholine muscarinic antagonist | 0.175 0.032 DBMET00324 0.11 0.079 DBMET00343 0.138 0.051 DBMET00957 0.122 0.065 DBMET00954 0.115 0.072 DBMET00956 | DBMET00324 | |
| 0.138 | 0.052 | 0.146 | Cholesterol synthesis inhibitor | 0.146 0.047 DBMET00324 0.106 0.08 DBMET00966 0.11 0.075 DBMET00954 | DBMET00324 | |
| 0.202 | 0.117 | 0.202 | Cardiotonic | 0.185 0.134 DBMET00324 0.182 0.137 DBMET00343 0.164 0.159 DBMET00957 | ||
| 0.217 | 0.132 | 0.229 | Hypoxia-inducible factor 1 alpha inhibitor | 0.202 0.149 DBMET00324 0.229 0.12 DBMET00966 | DBMET00966 | |
| 0.133 | 0.049 | 0.157 | Microtubule formation inhibitor | 0.115 0.067 DBMET00324 0.118 0.063 DBMET00343 0.157 0.034 DBMET00966 0.103 0.085 DBMET00957 0.125 0.055 DBMET00954 0.106 0.08 DBMET00956 | DBMET00966 | |
| 0.127 | 0.044 | 0.154 | Nav1.1 sodium channel blocker | 0.146 0.035 DBMET00324 0.117 0.05 DBMET00343 0.132 0.041 DBMET00957 0.091 0.079 DBMET00954 0.154 0.032 DBMET00956 | DBMET00956 | |
| 0.154 | 0.071 | 0.197 | Acetylcholine M1 receptor antagonist | 0.197 0.044 DBMET00324 0.15 0.074 DBMET00343 0.193 0.045 DBMET00957 0.166 0.061 DBMET00954 0.177 0.054 DBMET00956 | DBMET00324 | |
| 0.153 | 0.071 | 0.169 | CF transmembrane conductance regulator agonist | 0.161 0.058 DBMET00324 0.136 0.105 DBMET00343 0.144 0.087 DBMET00957 0.147 0.081 DBMET00954 0.169 0.047 DBMET00956 | DBMET00956 | |
| 0.153 | 0.074 | 0.153 | Cholinergic | 0.133 0.092 DBMET00324 | ||
| 0.197 | 0.122 | 0.55 | Immunostimulant | 0.274 0.087 DBMET00324 0.154 0.152 DBMET00343 0.55 0.023 DBMET00966 0.225 0.107 DBMET00957 0.309 0.076 DBMET00956 | DBMET00966 | |
| 0.084 | 0.012 | 0.092 | Calcium channel P-type blocker | 0.092 0.008 DBMET00954 | DBMET00954 | |
| 0.202 | 0.131 | 0.339 | Tyrosine 3 hydroxylase inhibitor | 0.267 0.053 DBMET00324 0.209 0.12 DBMET00343 0.275 0.047 DBMET00957 0.214 0.113 DBMET00954 0.339 0.019 DBMET00956 | DBMET00956 | |
| 0.164 | 0.095 | 0.409 | Hepatoprotectant | 0.173 0.087 DBMET00324 0.158 0.102 DBMET00343 0.409 0.012 DBMET00966 0.166 0.093 DBMET00957 0.175 0.084 DBMET00956 | DBMET00966 | |
| 0.117 | 0.049 | 0.117 | Butyrylcholinesterase inhibitor | 0.104 0.059 DBMET00324 | ||
| 0.099 | 0.032 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.11 0.023 DBMET00324 0.082 0.048 DBMET00343 0.13 0.012 DBMET00966 0.098 0.033 DBMET00957 0.124 0.014 DBMET00954 0.122 0.015 DBMET00956 | DBMET00966 | |
| 0.134 | 0.073 | 0.134 | Calcium channel blocker | 0.107 0.104 DBMET00954 | ||
| 0.134 | 0.075 | 0.18 | Nav1.6 sodium channel blocker | 0.128 0.084 DBMET00324 0.13 0.081 DBMET00343 0.124 0.09 DBMET00957 0.18 0.028 DBMET00954 0.131 0.079 DBMET00956 | DBMET00954 | |
| 0.073 | 0.016 | 0.08 | 5 Hydroxytryptamine 4 antagonist | 0.059 0.025 DBMET00324 0.08 0.013 DBMET00343 0.064 0.02 DBMET00957 0.048 0.042 DBMET00956 | DBMET00343 | |
| 0.108 | 0.052 | 0.141 | Anabolic | 0.138 0.025 DBMET00324 0.103 0.059 DBMET00343 0.133 0.029 DBMET00957 0.132 0.029 DBMET00954 0.141 0.023 DBMET00956 | DBMET00956 | |
| 0.063 | 0.009 | 0.068 | GABA uptake inhibitor | 0.068 0.007 DBMET00324 0.044 0.021 DBMET00343 0.047 0.018 DBMET00957 0.046 0.019 DBMET00954 0.062 0.009 DBMET00956 | DBMET00324 | |
| 0.072 | 0.02 | 0.072 | Glycine transporter inhibitor | 0.067 0.022 DBMET00324 0.062 0.024 DBMET00343 0.058 0.026 DBMET00957 | ||
| 0.213 | 0.161 | 0.379 | Vasodilator, peripheral | 0.379 0.062 DBMET00343 0.34 0.078 DBMET00957 0.216 0.158 DBMET00954 | DBMET00343 | |
| 0.166 | 0.114 | 0.21 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.172 0.104 DBMET00324 0.21 0.064 DBMET00954 0.194 0.077 DBMET00956 | DBMET00954 | |
| 0.066 | 0.015 | 0.066 | Alpha 1L adrenoreceptor antagonist | 0.049 0.047 DBMET00324 | ||
| 0.085 | 0.035 | 0.085 | Calcium channel L-type blocker | 0.066 0.058 DBMET00954 | ||
| 0.09 | 0.041 | 0.1 | Estrogen-related receptor beta agonist | 0.1 0.024 DBMET00324 0.08 0.068 DBMET00343 0.089 0.042 DBMET00957 0.084 0.055 DBMET00954 0.08 0.066 DBMET00956 | DBMET00324 | |
| 0.055 | 0.009 | 0.071 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.071 0.006 DBMET00324 0.033 0.021 DBMET00957 0.043 0.014 DBMET00954 0.061 0.008 DBMET00956 | DBMET00324 | |
| 0.129 | 0.084 | 0.266 | Protein kinase stimulant | 0.137 0.078 DBMET00324 0.131 0.083 DBMET00343 0.266 0.023 DBMET00966 0.138 0.077 DBMET00957 0.141 0.075 DBMET00954 0.16 0.061 DBMET00956 | DBMET00966 | |
| 0.119 | 0.074 | 0.153 | Cholinergic antagonist | 0.153 0.051 DBMET00324 0.123 0.071 DBMET00957 0.116 0.078 DBMET00954 | DBMET00324 | |
| 0.081 | 0.039 | 0.081 | Dopamine D2 antagonist | 0.073 0.042 DBMET00324 0.064 0.047 DBMET00343 0.058 0.051 DBMET00957 | ||
| 0.116 | 0.074 | 0.148 | Acetylcholine antagonist | 0.148 0.051 DBMET00324 0.117 0.073 DBMET00957 0.114 0.076 DBMET00954 | DBMET00324 | |
| 0.1 | 0.059 | 0.122 | Sphingomyelinase inhibitor | 0.122 0.04 DBMET00343 | DBMET00343 | |
| 0.071 | 0.03 | 0.071 | 5 Hydroxytryptamine 5A antagonist | 0.068 0.033 DBMET00324 0.07 0.031 DBMET00343 0.067 0.034 DBMET00957 | ||
| 0.119 | 0.078 | 0.285 | Cyclooxygenase 3 inhibitor | 0.113 0.086 DBMET00324 0.117 0.081 DBMET00343 0.285 0.006 DBMET00966 0.111 0.088 DBMET00957 0.13 0.067 DBMET00954 0.144 0.053 DBMET00956 | DBMET00966 | |
| 0.048 | 0.013 | 0.056 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.056 0.009 DBMET00324 | DBMET00324 | |
| 0.049 | 0.015 | 0.068 | Nociceptin (N/OFQ) receptor antagonist | 0.068 0.009 DBMET00324 0.036 0.024 DBMET00343 0.049 0.015 DBMET00957 0.05 0.015 DBMET00956 | DBMET00324 | |
| 0.08 | 0.046 | 0.089 | Alpha 1b adrenoreceptor antagonist | 0.089 0.04 DBMET00343 0.068 0.054 DBMET00957 0.065 0.056 DBMET00954 | DBMET00343 | |
| 0.064 | 0.031 | 0.065 | 5 Hydroxytryptamine 5 antagonist | 0.059 0.039 DBMET00324 0.065 0.03 DBMET00343 0.059 0.038 DBMET00957 | DBMET00343 | |
| 0.055 | 0.022 | 0.086 | Estradiol 17 beta-dehydrogenase inhibitor | 0.086 0.012 DBMET00324 0.039 0.032 DBMET00957 0.051 0.024 DBMET00956 | DBMET00324 | |
| 0.094 | 0.061 | 0.094 | Alpha adrenoreceptor antagonist | 0.078 0.074 DBMET00343 | ||
| 0.074 | 0.041 | 0.089 | Leukotriene synthesis inhibitor | 0.076 0.04 DBMET00324 0.065 0.049 DBMET00343 0.065 0.048 DBMET00957 0.089 0.032 DBMET00956 | DBMET00956 | |
| 0.133 | 0.102 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.142 0.064 DBMET00324 0.138 0.081 DBMET00966 0.133 0.102 DBMET00957 0.144 0.059 DBMET00956 | DBMET00956 | |
| 0.176 | 0.145 | 0.482 | 5 Hydroxytryptamine release stimulant | 0.198 0.123 DBMET00324 0.259 0.085 DBMET00343 0.3 0.07 DBMET00957 0.482 0.03 DBMET00954 0.288 0.074 DBMET00956 | DBMET00954 | |
| 0.088 | 0.057 | 0.088 | Calcium antagonist | |||
| 0.036 | 0.006 | 0.04 | Hedgehog signaling activator | 0.03 0.013 DBMET00324 0.031 0.011 DBMET00343 0.026 0.024 DBMET00957 0.04 0.004 DBMET00954 0.027 0.022 DBMET00956 | DBMET00954 | |
| 0.074 | 0.044 | 0.074 | 5 Hydroxytryptamine 1A antagonist | 0.058 0.055 DBMET00343 | ||
| 0.078 | 0.049 | 0.078 | Dopamine antagonist | 0.073 0.052 DBMET00324 0.064 0.06 DBMET00343 | ||
| 0.271 | 0.244 | 0.729 | Antiinflammatory | 0.339 0.181 DBMET00324 0.729 0.026 DBMET00966 0.31 0.207 DBMET00957 0.293 0.222 DBMET00954 0.341 0.179 DBMET00956 | DBMET00966 | |
| 0.17 | 0.143 | 0.521 | Antioxidant | 0.219 0.102 DBMET00324 0.521 0.018 DBMET00966 0.193 0.119 DBMET00957 0.19 0.123 DBMET00956 | DBMET00966 | |
| 0.076 | 0.049 | 0.076 | 5 Hydroxytryptamine 1 antagonist | 0.069 0.055 DBMET00343 | ||
| 0.052 | 0.027 | 0.052 | Potassium channel Kv1.3 blocker | 0.05 0.029 DBMET00954 | ||
| 0.083 | 0.058 | 0.091 | Histamine H2 receptor antagonist | 0.081 0.062 DBMET00324 0.091 0.045 DBMET00343 0.089 0.048 DBMET00957 | DBMET00343 | |
| 0.058 | 0.035 | 0.058 | Pregnane X receptor antagonist | 0.055 0.045 DBMET00324 0.055 0.043 DBMET00954 | ||
| 0.243 | 0.222 | 0.493 | Apoptosis agonist | 0.235 0.231 DBMET00343 0.493 0.077 DBMET00966 0.252 0.212 DBMET00954 | DBMET00966 | |
| 0.102 | 0.082 | 0.124 | Acetylcholine release stimulant | 0.124 0.042 DBMET00954 | DBMET00954 | |
| 0.13 | 0.11 | 0.261 | Interferon gamma antagonist | 0.141 0.09 DBMET00324 0.13 0.11 DBMET00343 0.261 0.026 DBMET00966 0.142 0.09 DBMET00957 0.174 0.054 DBMET00954 0.159 0.067 DBMET00956 | DBMET00966 | |
| 0.138 | 0.118 | 0.147 | Amyloid beta aggregation inhibitor | 0.147 0.11 DBMET00324 | DBMET00324 | |
| 0.101 | 0.081 | 0.101 | Electron transport complex I inhibitor | |||
| 0.08 | 0.063 | 0.12 | CC chemokine 5 receptor agonist | 0.111 0.012 DBMET00324 0.086 0.046 DBMET00343 0.12 0.009 DBMET00957 0.108 0.015 DBMET00956 | DBMET00957 | |
| 0.135 | 0.12 | 0.136 | Amyloid beta precursor protein antagonist | 0.136 0.119 DBMET00324 | DBMET00324 | |
| 0.206 | 0.191 | 0.472 | Immunosuppressant | 0.212 0.185 DBMET00324 0.472 0.041 DBMET00966 0.218 0.179 DBMET00954 | DBMET00966 | |
| 0.197 | 0.183 | 0.405 | Apoptosis antagonist | 0.219 0.158 DBMET00324 0.195 0.186 DBMET00343 0.405 0.037 DBMET00966 0.214 0.162 DBMET00957 0.202 0.176 DBMET00956 | DBMET00966 | |
| 0.179 | 0.165 | 0.198 | Lipoxygenase inhibitor | 0.179 0.165 DBMET00324 0.198 0.143 DBMET00956 | DBMET00956 | |
| 0.103 | 0.09 | 0.146 | Estrogen antagonist | 0.146 0.025 DBMET00324 0.133 0.035 DBMET00957 0.108 0.08 DBMET00954 0.139 0.029 DBMET00956 | DBMET00324 | |
| 0.034 | 0.022 | 0.063 | Melatonin receptor 1A agonist | 0.063 0.005 DBMET00343 0.032 0.026 DBMET00957 0.049 0.008 DBMET00954 | DBMET00343 | |
| 0.017 | 0.006 | 0.02 | Antibiotic Tetracycline-like | 0.02 0.004 DBMET00324 0.015 0.013 DBMET00343 0.016 0.01 DBMET00966 0.017 0.007 DBMET00957 0.019 0.005 DBMET00956 | DBMET00324 | |
| 0.086 | 0.075 | 0.112 | 5-Lipoxygenase inhibitor | 0.103 0.062 DBMET00324 0.112 0.055 DBMET00956 | DBMET00956 | |
| 0.056 | 0.046 | 0.084 | Acetylcholine M3 receptor antagonist | 0.084 0.024 DBMET00324 0.075 0.029 DBMET00957 0.064 0.037 DBMET00956 | DBMET00324 | |
| 0.073 | 0.064 | 0.073 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.09 | 0.081 | 0.254 | Expectorant | 0.092 0.078 DBMET00343 0.254 0.012 DBMET00966 0.093 0.077 DBMET00954 0.095 0.075 DBMET00956 | DBMET00966 | |
| 0.089 | 0.081 | 0.089 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.045 | 0.038 | 0.098 | Sigma receptor antagonist | 0.058 0.029 DBMET00324 0.098 0.017 DBMET00954 | DBMET00954 | |
| 0.043 | 0.037 | 0.061 | Adenylate cyclase 1 inhibitor | 0.045 0.033 DBMET00324 0.058 0.019 DBMET00343 0.061 0.017 DBMET00957 0.045 0.034 DBMET00956 | DBMET00957 | |
| 0.071 | 0.066 | 0.093 | Estrogen receptor alpha antagonist | 0.093 0.032 DBMET00324 0.074 0.06 DBMET00957 0.081 0.047 DBMET00956 | DBMET00324 | |
| 0.046 | 0.041 | 0.069 | Topoisomerase II beta inhibitor | 0.069 0.017 DBMET00324 0.051 0.032 DBMET00966 0.067 0.018 DBMET00957 | DBMET00324 | |
| 0.02 | 0.016 | 0.036 | Nociceptin (N/OFQ) receptor agonist | 0.027 0.011 DBMET00324 0.02 0.015 DBMET00343 0.028 0.01 DBMET00957 0.036 0.008 DBMET00956 | DBMET00956 | |
| 0.059 | 0.058 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.063 0.046 DBMET00324 0.059 0.057 DBMET00343 0.064 0.046 DBMET00957 | DBMET00957 | |
| 0.014 | 0.013 | 0.112 | NMDA receptor phencyclidine site antagonist | 0.019 0.008 DBMET00324 0.02 0.007 DBMET00343 0.027 0.005 DBMET00957 0.112 0.002 DBMET00954 0.03 0.004 DBMET00956 | DBMET00954 | |
| 0.039 | 0.038 | 0.046 | Nerve growth factor antagonist | 0.046 0.024 DBMET00324 0.04 0.035 DBMET00957 | DBMET00324 | |
| 0.078 | 0.077 | 0.11 | Vanilloid agonist | 0.08 0.07 DBMET00324 0.104 0.029 DBMET00343 0.11 0.024 DBMET00957 0.087 0.053 DBMET00956 | DBMET00957 | |
| 0.045 | 0.045 | 0.052 | Squalene epoxidase inhibitor | 0.052 0.031 DBMET00324 | DBMET00324 | |
| 0.031 | 0.032 | 0.037 | Protein kinase C beta I inhibitor | 0.037 0.013 DBMET00324 0.034 0.021 DBMET00966 0.034 0.023 DBMET00957 0.032 0.03 DBMET00956 | DBMET00324 | |
| 0.061 | 0.063 | 0.062 | Glutamate (mGluR7) antagonist | 0.062 0.061 DBMET00954 | DBMET00954 | |
| 0.05 | 0.054 | 0.068 | Acetylcholine M2 receptor antagonist | 0.065 0.04 DBMET00324 0.068 0.038 DBMET00954 | DBMET00954 | |
| 0.09 | 0.094 | 0.169 | Adenylate cyclase inhibitor | 0.141 0.051 DBMET00324 0.125 0.063 DBMET00343 0.169 0.034 DBMET00957 0.148 0.046 DBMET00956 | DBMET00957 | |
| 0.086 | 0.092 | 0.129 | Estrogen receptor beta antagonist | 0.129 0.024 DBMET00324 0.119 0.033 DBMET00957 0.127 0.026 DBMET00956 | DBMET00324 | |
| 0.15 | 0.156 | 0.304 | Vasodilator | 0.304 0.046 DBMET00966 0.184 0.118 DBMET00954 0.184 0.118 DBMET00956 | DBMET00966 | |
| 0.12 | 0.126 | 0.171 | Sphingosine 1-phosphate receptor 5 antagonist | 0.128 0.104 DBMET00324 0.171 0.032 DBMET00956 | DBMET00956 | |
| 0.019 | 0.026 | 0.065 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET00324 0.022 0.019 DBMET00343 0.065 0.005 DBMET00966 0.028 0.014 DBMET00957 0.029 0.013 DBMET00956 | DBMET00966 | |
| 0.019 | 0.027 | 0.034 | Sigma 2 receptor antagonist | 0.034 0.015 DBMET00954 | DBMET00954 | |
| 0.142 | 0.151 | 0.22 | Neurotrophic factor enhancer | 0.198 0.078 DBMET00324 0.163 0.119 DBMET00343 0.204 0.073 DBMET00966 0.22 0.059 DBMET00957 0.199 0.077 DBMET00954 0.216 0.063 DBMET00956 | DBMET00957 | |
| 0.088 | 0.098 | 0.097 | Mucolytic | 0.097 0.082 DBMET00954 0.092 0.089 DBMET00956 | DBMET00954 | |
| 0.125 | 0.136 | 0.206 | Interleukin 6 antagonist | 0.129 0.127 DBMET00324 0.14 0.106 DBMET00343 0.206 0.037 DBMET00966 0.145 0.097 DBMET00957 0.133 0.118 DBMET00956 | DBMET00966 | |
| 0.034 | 0.044 | 0.036 | Vanilloid 3 antagonist | 0.036 0.032 DBMET00954 | DBMET00954 | |
| 0.078 | 0.091 | 0.111 | Chemokine receptor antagonist | 0.111 0.054 DBMET00324 0.084 0.082 DBMET00957 | DBMET00324 | |
| 0.073 | 0.087 | 0.089 | Ca(v)3.1 blocker | 0.08 0.062 DBMET00324 0.082 0.055 DBMET00343 0.089 0.038 DBMET00957 | DBMET00957 | |
| 0.11 | 0.125 | 0.15 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.107 DBMET00324 0.115 0.109 DBMET00343 0.121 0.093 DBMET00957 0.15 0.041 DBMET00956 | DBMET00956 | |
| 0.067 | 0.082 | 0.132 | Glycine receptor antagonist | 0.082 0.054 DBMET00324 0.132 0.013 DBMET00966 | DBMET00966 | |
| 0.034 | 0.05 | 0.094 | Estrogen agonist | 0.094 0.019 DBMET00324 0.052 0.034 DBMET00966 0.072 0.025 DBMET00957 0.091 0.019 DBMET00956 | DBMET00324 | |
| 0.019 | 0.036 | 0.049 | Squalene synthetase inhibitor | 0.049 0.015 DBMET00966 | DBMET00966 | |
| 0.1 | 0.117 | 0.25 | Lipid peroxidase inhibitor | 0.136 0.079 DBMET00324 0.25 0.027 DBMET00966 | DBMET00966 | |
| 0.02 | 0.037 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.024 0.018 DBMET00343 | DBMET00343 | |
| 0.05 | 0.068 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 DBMET00966 0.064 0.028 DBMET00954 | DBMET00966 | |
| 0.043 | 0.061 | 0.056 | Leukotriene B4 antagonist | 0.056 0.033 DBMET00966 | DBMET00966 | |
| 0.017 | 0.037 | 0.079 | Estrogen receptor alpha agonist | 0.079 0.012 DBMET00324 0.056 0.016 DBMET00957 0.079 0.012 DBMET00956 | DBMET00956 | |
| 0.06 | 0.08 | 0.09 | Glycine receptor agonist | 0.088 0.03 DBMET00954 0.09 0.028 DBMET00956 | DBMET00956 | |
| 0.026 | 0.048 | 0.035 | Protein kinase C beta II inhibitor | 0.035 0.018 DBMET00324 | DBMET00324 | |
| 0.078 | 0.1 | 0.106 | Glutamate release inhibitor | 0.106 0.035 DBMET00954 | DBMET00954 | |
| 0.014 | 0.037 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.007 DBMET00966 0.019 0.014 DBMET00956 | DBMET00966 | |
| 0.158 | 0.181 | 0.176 | 5 Hydroxytryptamine 3E antagonist | 0.176 0.118 DBMET00324 0.176 0.115 DBMET00957 0.165 0.153 DBMET00956 | DBMET00957 | |
| 0.105 | 0.13 | 0.205 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 DBMET00324 0.175 0.018 DBMET00343 0.205 0.009 DBMET00957 0.13 0.061 DBMET00954 0.162 0.025 DBMET00956 | DBMET00957 | |
| 0.028 | 0.053 | 0.041 | Delayed rectifier potassium channel blocker | 0.037 0.027 DBMET00343 0.041 0.02 DBMET00957 | DBMET00957 | |
| 0.007 | 0.032 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 DBMET00343 | DBMET00343 | |
| 0.033 | 0.059 | 0.052 | Microtubule stabilization | 0.052 0.025 DBMET00966 | DBMET00966 | |
| 0.037 | 0.065 | 0.055 | Alpha 1d adrenoreceptor antagonist | 0.055 0.044 DBMET00343 | DBMET00343 | |
| 0.035 | 0.064 | 0.1 | Protein 50S ribosomal subunit inhibitor | 0.1 0.013 DBMET00966 | DBMET00966 | |
| 0.067 | 0.096 | 0.11 | MAP kinase kinase 7 inhibitor | 0.092 0.022 DBMET00324 0.093 0.02 DBMET00957 0.11 0.007 DBMET00956 | DBMET00956 | |
| 0.081 | 0.112 | 0.119 | Glutamate (mGluR7) agonist | 0.119 0.031 DBMET00343 0.092 0.079 DBMET00957 0.097 0.066 DBMET00954 | DBMET00343 | |
| 0.04 | 0.07 | 0.11 | NMDA 2B receptor antagonist | 0.08 0.021 DBMET00324 0.083 0.02 DBMET00957 0.11 0.013 DBMET00956 | DBMET00956 | |
| 0.124 | 0.156 | 0.133 | Heat shock protein 70 antagonist | 0.13 0.123 DBMET00324 0.133 0.104 DBMET00966 0.13 0.121 DBMET00956 | DBMET00966 | |
| 0.086 | 0.12 | 0.131 | TRPA1 agonist | 0.101 0.086 DBMET00324 0.1 0.087 DBMET00957 0.131 0.047 DBMET00954 0.109 0.073 DBMET00956 | DBMET00954 | |
| 0.071 | 0.105 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.056 DBMET00954 | DBMET00954 | |
| 0.073 | 0.109 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.056 DBMET00324 0.084 0.083 DBMET00957 0.085 0.081 DBMET00956 | DBMET00324 | |
| 0.01 | 0.047 | 0.093 | Estrogen receptor beta agonist | 0.086 0.013 DBMET00324 0.054 0.019 DBMET00957 0.093 0.013 DBMET00956 | DBMET00956 | |
| 0.012 | 0.05 | 0.033 | RNA-directed RNA polymerase stimulant | 0.033 0.019 DBMET00954 | DBMET00954 | |
| 0.071 | 0.112 | 0.353 | GABA C receptor agonist | 0.12 0.05 DBMET00324 0.129 0.044 DBMET00957 0.125 0.046 DBMET00954 0.353 0.007 DBMET00956 | DBMET00956 | |
| 0.083 | 0.124 | 0.102 | Tubulin antagonist | 0.102 0.099 DBMET00954 | DBMET00954 | |
| 0.023 | 0.066 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 DBMET00324 | DBMET00324 | |
| 0.038 | 0.082 | 0.126 | 5 Hydroxytryptamine 2A agonist | 0.079 0.028 DBMET00343 0.075 0.032 DBMET00957 0.126 0.008 DBMET00954 0.095 0.016 DBMET00956 | DBMET00954 | |
| 0.048 | 0.092 | 0.08 | Protein kinase C beta inhibitor | 0.08 0.03 DBMET00324 0.071 0.046 DBMET00957 0.069 0.05 DBMET00956 | DBMET00324 | |
| 0.131 | 0.175 | 0.449 | Free radical scavenger | 0.169 0.125 DBMET00324 0.449 0.022 DBMET00966 | DBMET00966 | |
| 0.019 | 0.064 | 0.035 | Melatonin 2 agonist | 0.035 0.02 DBMET00343 | DBMET00343 | |
| 0.073 | 0.119 | 0.118 | Cystathionine beta-synthase inhibitor | 0.094 0.084 DBMET00324 0.118 0.06 DBMET00956 | DBMET00956 | |
| 0.019 | 0.065 | 0.041 | Melatonin agonist | 0.041 0.014 DBMET00343 | DBMET00343 | |
| 0.037 | 0.083 | 0.076 | Glucose-6-phosphate translocase inhibitor | 0.076 0.013 DBMET00966 | DBMET00966 | |
| 0.057 | 0.104 | 0.081 | Interferon agonist | 0.081 0.051 DBMET00966 | DBMET00966 | |
| 0.03 | 0.078 | 0.042 | Kainate receptor agonist | 0.042 0.027 DBMET00956 | DBMET00956 | |
| 0.006 | 0.053 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.011 DBMET00966 | DBMET00966 | |
| 0.019 | 0.069 | 0.043 | Melatonin 1 agonist | 0.043 0.013 DBMET00343 | DBMET00343 | |
| 0.016 | 0.068 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 DBMET00966 | DBMET00966 | |
| 0.03 | 0.084 | 0.09 | 5 Hydroxytryptamine 2 agonist | 0.052 0.036 DBMET00343 0.045 0.043 DBMET00957 0.09 0.012 DBMET00954 0.049 0.039 DBMET00956 | DBMET00954 | |
| 0.049 | 0.103 | 0.068 | CC chemokine receptor antagonist | 0.068 0.065 DBMET00957 | DBMET00957 | |
| 0.019 | 0.075 | 0.091 | NMDA receptor subunit 3A antagonist | 0.044 0.023 DBMET00324 0.046 0.022 DBMET00957 0.091 0.009 DBMET00956 | DBMET00956 | |
| 0.206 | 0.264 | 0.429 | Calcium channel L-type activator | 0.288 0.168 DBMET00324 0.372 0.101 DBMET00343 0.429 0.062 DBMET00957 0.253 0.202 DBMET00954 0.324 0.137 DBMET00956 | DBMET00957 | |
| 0.022 | 0.08 | 0.09 | Dopamine D5 agonist | 0.05 0.017 DBMET00324 0.052 0.016 DBMET00957 0.09 0.005 DBMET00956 | DBMET00956 | |
| 0.008 | 0.07 | 0.019 | Melatonin 1 antagonist | 0.019 0.013 DBMET00343 | DBMET00343 | |
| 0.082 | 0.144 | 0.119 | Toll-Like receptor 2 antagonist | 0.119 0.079 DBMET00956 | DBMET00956 | |
| 0.011 | 0.073 | 0.037 | Dopamine D1 agonist | 0.023 0.015 DBMET00966 0.022 0.018 DBMET00957 0.021 0.018 DBMET00954 0.037 0.006 DBMET00956 | DBMET00956 | |
| 0.013 | 0.076 | 0.035 | Progesterone antagonist | 0.035 0.025 DBMET00954 | DBMET00954 | |
| 0.083 | 0.149 | 0.161 | Nav1.2 sodium channel blocker | 0.161 0.051 DBMET00954 | DBMET00954 | |
| 0.047 | 0.113 | 0.065 | Heme oxygenase stimulant | 0.065 0.035 DBMET00954 | DBMET00954 | |
| 0.063 | 0.13 | 0.129 | Transcription factor NF kappa B stimulant | 0.129 0.021 DBMET00966 | DBMET00966 | |
| 0.012 | 0.079 | 0.034 | Glucocorticoid antagonist | 0.034 0.021 DBMET00954 | DBMET00954 | |
| 0.035 | 0.102 | 0.227 | NMDA 2 receptor antagonist | 0.107 0.028 DBMET00324 0.066 0.055 DBMET00343 0.171 0.013 DBMET00957 0.123 0.023 DBMET00954 0.227 0.007 DBMET00956 | DBMET00956 | |
| 0.071 | 0.139 | 0.194 | GABA C receptor antagonist | 0.114 0.059 DBMET00324 0.135 0.04 DBMET00957 0.111 0.063 DBMET00954 0.194 0.014 DBMET00956 | DBMET00956 | |
| 0.145 | 0.214 | 0.325 | DNA synthesis inhibitor | 0.185 0.147 DBMET00324 0.176 0.16 DBMET00343 0.325 0.036 DBMET00966 0.211 0.107 DBMET00957 0.188 0.141 DBMET00954 0.244 0.071 DBMET00956 | DBMET00966 | |
| 0.023 | 0.093 | 0.068 | Antibiotic Aminoglycoside-like | 0.033 0.031 DBMET00343 0.068 0.006 DBMET00966 0.034 0.029 DBMET00957 0.035 0.027 DBMET00956 | DBMET00966 | |
| 0.01 | 0.083 | 0.03 | Melatonin antagonist | 0.03 0.017 DBMET00343 | DBMET00343 | |
| 0.011 | 0.084 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.053 0.006 DBMET00966 | DBMET00966 | |
| 0.018 | 0.093 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET00966 | DBMET00966 | |
| 0.055 | 0.13 | 0.191 | Topoisomerase I inhibitor | 0.191 0.029 DBMET00966 | DBMET00966 | |
| 0.009 | 0.084 | 0.064 | Arginase inhibitor | 0.032 0.029 DBMET00324 0.064 0.009 DBMET00966 0.035 0.026 DBMET00956 | DBMET00966 | |
| 0.136 | 0.212 | 0.245 | Superoxide dismutase inhibitor | 0.245 0.078 DBMET00954 0.233 0.086 DBMET00956 | DBMET00954 | |
| 0.022 | 0.098 | 0.103 | NMDA receptor subunit 3B antagonist | 0.04 0.035 DBMET00324 0.05 0.025 DBMET00957 0.103 0.01 DBMET00956 | DBMET00956 | |
| 0.034 | 0.111 | 0.166 | Antineoplastic antibiotic | 0.166 0.028 DBMET00966 | DBMET00966 | |
| 0.026 | 0.106 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.046 0.043 DBMET00957 0.051 0.035 DBMET00956 | DBMET00956 | |
| 0.013 | 0.093 | 0.049 | Sodium/glucose cotransporter inhibitor | 0.049 0.005 DBMET00966 | DBMET00966 | |
| 0.075 | 0.158 | 0.115 | Photosensitizer | 0.115 0.063 DBMET00966 | DBMET00966 | |
| 0.006 | 0.089 | 0.09 | Sigma 1 receptor antagonist | 0.09 0.007 DBMET00954 | DBMET00954 | |
| 0.066 | 0.151 | 0.136 | Nav1.3 sodium channel blocker | 0.136 0.058 DBMET00954 | DBMET00954 | |
| 0.021 | 0.106 | 0.072 | Aromatase inhibitor | 0.072 0.033 DBMET00954 | DBMET00954 | |
| 0.063 | 0.148 | 0.09 | Protein kinase C zeta inhibitor | 0.087 0.071 DBMET00954 0.09 0.065 DBMET00956 | DBMET00956 | |
| 0.042 | 0.129 | 0.059 | Interferon inducer | 0.059 0.057 DBMET00966 | DBMET00966 | |
| 0.047 | 0.135 | 0.088 | Histamine N-methyltransferase inhibitor | 0.088 0.058 DBMET00324 0.078 0.069 DBMET00956 | DBMET00324 | |
| 0.02 | 0.108 | 0.043 | Glutamate (mGluR3) agonist | 0.031 0.027 DBMET00957 0.033 0.02 DBMET00954 0.043 0.008 DBMET00956 | DBMET00956 | |
| 0.139 | 0.228 | 0.366 | Peptidyltransferase inhibitor | 0.175 0.138 DBMET00324 0.169 0.149 DBMET00343 0.366 0.01 DBMET00966 0.206 0.092 DBMET00957 0.187 0.117 DBMET00956 | DBMET00966 | |
| 0.028 | 0.119 | 0.072 | Alpha-mannosidase inhibitor | 0.072 0.015 DBMET00966 | DBMET00966 | |
| 0.071 | 0.163 | 0.153 | DOPA decarboxylase inhibitor | 0.107 0.062 DBMET00324 0.102 0.072 DBMET00957 0.093 0.09 DBMET00954 0.153 0.019 DBMET00956 | DBMET00956 | |
| 0.172 | 0.264 | 0.221 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.208 0.144 DBMET00343 0.221 0.114 DBMET00957 | DBMET00957 | |
| 0.085 | 0.177 | 0.599 | Angiogenesis stimulant | 0.599 0.007 DBMET00966 0.154 0.12 DBMET00957 0.207 0.091 DBMET00956 | DBMET00966 | |
| 0.065 | 0.159 | 0.089 | T cell inhibitor | 0.089 0.04 DBMET00966 | DBMET00966 | |
| 0.032 | 0.128 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.04 DBMET00324 | DBMET00324 | |
| 0.017 | 0.112 | 0.104 | NMDA 2A receptor antagonist | 0.051 0.037 DBMET00324 0.095 0.014 DBMET00957 0.09 0.016 DBMET00954 0.104 0.012 DBMET00956 | DBMET00956 | |
| 0.028 | 0.124 | 0.056 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.056 0.035 DBMET00956 | DBMET00956 | |
| 0.039 | 0.137 | 0.111 | Topoisomerase II alpha inhibitor | 0.111 0.033 DBMET00966 | DBMET00966 | |
| 0.038 | 0.139 | 0.134 | Phosphodiesterase IV inhibitor | 0.134 0.027 DBMET00954 | DBMET00954 | |
| 0.053 | 0.155 | 0.093 | GABA B receptor agonist | 0.08 0.042 DBMET00954 0.093 0.023 DBMET00956 | DBMET00956 | |
| 0.088 | 0.19 | 0.166 | DNA repair enzyme inhibitor | 0.166 0.019 DBMET00966 | DBMET00966 | |
| 0.022 | 0.125 | 0.073 | 5 Hydroxytryptamine 2B agonist | 0.036 0.035 DBMET00343 0.073 0.005 DBMET00954 0.047 0.015 DBMET00956 | DBMET00954 | |
| 0.149 | 0.252 | 0.587 | Antithrombotic | 0.587 0.018 DBMET00966 0.2 0.177 DBMET00957 0.214 0.161 DBMET00954 0.261 0.118 DBMET00956 | DBMET00966 | |
| 0.062 | 0.166 | 0.094 | Protein kinase C gamma inhibitor | 0.094 0.087 DBMET00956 | DBMET00956 | |
| 0.121 | 0.225 | 0.211 | DNA damaging | 0.183 0.131 DBMET00954 0.211 0.107 DBMET00956 | DBMET00956 | |
| 0.105 | 0.209 | 0.296 | Interleukin agonist | 0.296 0.05 DBMET00966 0.167 0.151 DBMET00954 | DBMET00966 | |
| 0.05 | 0.159 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.112 0.045 DBMET00954 0.196 0.012 DBMET00956 | DBMET00956 | |
| 0.026 | 0.137 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.031 DBMET00956 | DBMET00956 | |
| 0.107 | 0.218 | 0.152 | Succinate dehydrogenase inhibitor | 0.152 0.109 DBMET00956 | DBMET00956 | |
| 0.03 | 0.144 | 0.048 | Parathyroid hormone antagonist | 0.048 0.026 DBMET00954 | DBMET00954 | |
| 0.04 | 0.156 | 0.084 | GABA aminotransferase inhibitor | 0.084 0.041 DBMET00956 | DBMET00956 | |
| 0.108 | 0.225 | 0.16 | Phospholipase C inhibitor | 0.141 0.126 DBMET00324 0.14 0.127 DBMET00954 0.16 0.087 DBMET00956 | DBMET00956 | |
| 0.038 | 0.155 | 0.075 | Androgen antagonist | 0.075 0.072 DBMET00954 | DBMET00954 | |
| 0.057 | 0.175 | 0.184 | ABCA1 expression enhancer | 0.184 0.011 DBMET00954 | DBMET00954 | |
| 0.019 | 0.139 | 0.075 | NMDA 2C receptor antagonist | 0.062 0.042 DBMET00957 0.069 0.035 DBMET00954 0.075 0.029 DBMET00956 | DBMET00956 | |
| 0.026 | 0.147 | 0.055 | Alpha 2 adrenoreceptor agonist | 0.055 0.05 DBMET00957 | DBMET00957 | |
| 0.038 | 0.162 | 0.187 | NMDA receptor antagonist | 0.087 0.057 DBMET00324 0.131 0.031 DBMET00957 0.124 0.034 DBMET00954 0.187 0.016 DBMET00956 | DBMET00956 | |
| 0.017 | 0.143 | 0.061 | Mannosidase inhibitor | 0.061 0.016 DBMET00966 | DBMET00966 | |
| 0.044 | 0.173 | 0.083 | Keratolytic | 0.083 0.045 DBMET00954 0.073 0.06 DBMET00956 | DBMET00954 | |
| 0.023 | 0.153 | 0.059 | H+/K+-transporting ATPase inhibitor | 0.059 0.026 DBMET00343 0.054 0.031 DBMET00957 | DBMET00343 | |
| 0.053 | 0.187 | 0.093 | Bile acid receptor antagonist | 0.093 0.065 DBMET00954 | DBMET00954 | |
| 0.047 | 0.186 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.035 DBMET00966 | DBMET00966 | |
| 0.042 | 0.182 | 0.09 | Inducible nitric-oxide synthase inhibitor | 0.074 0.073 DBMET00957 0.09 0.047 DBMET00954 0.075 0.072 DBMET00956 | DBMET00954 | |
| 0.058 | 0.2 | 0.092 | Carbonic anhydrase XV inhibitor | 0.092 0.079 DBMET00956 | DBMET00956 | |
| 0.042 | 0.184 | 0.067 | Glutamate (mGluR6) antagonist | 0.067 0.045 DBMET00956 | DBMET00956 | |
| 0.046 | 0.189 | 0.172 | Topoisomerase II inhibitor | 0.172 0.04 DBMET00966 | DBMET00966 | |
| 0.047 | 0.191 | 0.08 | Vanilloid 4 agonist | 0.08 0.04 DBMET00957 | DBMET00957 | |
| 0.052 | 0.198 | 0.099 | Thioredoxin inhibitor | 0.099 0.049 DBMET00966 | DBMET00966 | |
| 0.032 | 0.177 | 0.083 | CYP2A6 inhibitor | 0.083 0.046 DBMET00954 | DBMET00954 | |
| 0.088 | 0.235 | 0.253 | Hypolipemic | 0.253 0.066 DBMET00966 | DBMET00966 | |
| 0.136 | 0.287 | 0.218 | Insulysin inhibitor | 0.193 0.167 DBMET00324 0.213 0.138 DBMET00957 0.218 0.131 DBMET00956 | DBMET00956 | |
| 0.12 | 0.274 | 0.242 | Gastrin inhibitor | 0.199 0.15 DBMET00343 0.209 0.135 DBMET00957 0.242 0.089 DBMET00954 0.203 0.145 DBMET00956 | DBMET00954 | |
| 0.04 | 0.194 | 0.084 | Carbonic anhydrase VI inhibitor | 0.084 0.052 DBMET00956 | DBMET00956 | |
| 0.017 | 0.173 | 0.157 | 5 Hydroxytryptamine agonist | 0.11 0.031 DBMET00343 0.105 0.032 DBMET00957 0.126 0.026 DBMET00954 0.157 0.02 DBMET00956 | DBMET00956 | |
| 0.004 | 0.162 | 0.022 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 DBMET00954 | DBMET00954 | |
| 0.105 | 0.264 | 0.143 | Neurotensin receptor agonist | 0.139 0.13 DBMET00957 0.143 0.119 DBMET00954 0.143 0.119 DBMET00956 | DBMET00956 | |
| 0.051 | 0.211 | 0.19 | AMP-activated protein kinase stimulant | 0.19 0.013 DBMET00966 0.095 0.078 DBMET00954 | DBMET00966 | |
| 0.082 | 0.242 | 0.133 | GABA C receptor rho-2 antagonist | 0.133 0.099 DBMET00957 | DBMET00957 | |
| 0.039 | 0.199 | 0.082 | Pim-3 kinase inhibitor | 0.082 0.072 DBMET00956 | DBMET00956 | |
| 0.065 | 0.226 | 0.316 | Peroxidase inhibitor | 0.115 0.106 DBMET00324 0.114 0.106 DBMET00957 0.316 0.034 DBMET00956 | DBMET00956 | |
| 0.008 | 0.168 | 0.083 | 5-Alpha-reductase inhibitor | 0.083 0.012 DBMET00954 | DBMET00954 | |
| 0.05 | 0.211 | 0.111 | DNA polymerase I inhibitor | 0.111 0.076 DBMET00966 | DBMET00966 | |
| 0.181 | 0.343 | 0.269 | 5 Hydroxytryptamine release inhibitor | 0.263 0.211 DBMET00966 0.251 0.226 DBMET00954 0.269 0.202 DBMET00956 | DBMET00956 | |
| 0.08 | 0.242 | 0.148 | Growth hormone agonist | 0.148 0.089 DBMET00956 | DBMET00956 | |
| 0.022 | 0.191 | 0.039 | Glucose-6-phosphate dehydrogenase inhibitor | 0.039 0.024 DBMET00954 | DBMET00954 | |
| 0.127 | 0.298 | 0.173 | Nitric-oxide synthase stimulant | 0.173 0.145 DBMET00956 | DBMET00956 | |
| 0.1 | 0.276 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.042 DBMET00966 | DBMET00966 | |
| 0.04 | 0.217 | 0.154 | Creatine kinase inhibitor | 0.112 0.047 DBMET00324 0.095 0.065 DBMET00957 0.154 0.022 DBMET00956 | DBMET00956 | |
| 0.047 | 0.226 | 0.121 | Alkylator | 0.121 0.067 DBMET00966 | DBMET00966 | |
| 0.04 | 0.22 | 0.099 | DNA intercalator | 0.099 0.074 DBMET00966 | DBMET00966 | |
| 0.004 | 0.186 | 0.016 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 DBMET00956 | DBMET00956 | |
| 0.012 | 0.198 | 0.114 | Factor XIa inhibitor | 0.109 0.005 DBMET00954 0.114 0.005 DBMET00956 | DBMET00956 | |
| 0.055 | 0.244 | 0.094 | Phosphodiesterase 6D inhibitor | 0.094 0.066 DBMET00966 | DBMET00966 | |
| 0.035 | 0.24 | 0.116 | Mediator release inhibitor | 0.116 0.052 DBMET00966 | DBMET00966 | |
| 0.021 | 0.227 | 0.058 | Aldosterone antagonist | 0.058 0.021 DBMET00954 | DBMET00954 | |
| 0.129 | 0.336 | 0.273 | Histamine release inhibitor | 0.273 0.139 DBMET00966 0.212 0.189 DBMET00957 | DBMET00966 | |
| 0.031 | 0.246 | 0.097 | Ornithine decarboxylase inhibitor | 0.097 0.048 DBMET00954 0.091 0.054 DBMET00956 | DBMET00954 | |
| 0.043 | 0.261 | 0.084 | NADH dehydrogenase inhibitor | 0.084 0.067 DBMET00966 | DBMET00966 | |
| 0.015 | 0.239 | 0.07 | Phosphofructokinase-1 inhibitor | 0.07 0.048 DBMET00966 | DBMET00966 | |
| 0.109 | 0.347 | 0.253 | Antiobesity | 0.253 0.153 DBMET00966 | DBMET00966 | |
| 0.03 | 0.269 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.043 DBMET00966 | DBMET00966 | |
| 0.013 | 0.257 | 0.057 | Alcohol oxidase inhibitor | 0.057 0.038 DBMET00956 | DBMET00956 | |
| 0.036 | 0.28 | 0.09 | 5 Hydroxytryptamine 3A agonist | 0.09 0.089 DBMET00956 | DBMET00956 | |
| 0.038 | 0.284 | 0.123 | Beta glucuronidase inhibitor | 0.123 0.043 DBMET00966 | DBMET00966 | |
| 0.04 | 0.289 | 0.177 | Amylase inhibitor | 0.177 0.052 DBMET00966 | DBMET00966 | |
| 0.015 | 0.267 | 0.061 | Phosphodiesterase 4B inhibitor | 0.061 0.054 DBMET00954 | DBMET00954 | |
| 0.006 | 0.264 | 0.168 | 5 Hydroxytryptamine 2C agonist | 0.168 0.005 DBMET00954 0.142 0.005 DBMET00956 | DBMET00954 | |
| 0.014 | 0.276 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.037 DBMET00966 | DBMET00966 | |
| 0.061 | 0.326 | 0.321 | Platelet adhesion inhibitor | 0.321 0.027 DBMET00966 | DBMET00966 | |
| 0.028 | 0.296 | 0.083 | Aminopeptidase B inhibitor | 0.083 0.079 DBMET00956 | DBMET00956 | |
| 0.032 | 0.303 | 0.114 | UDP-glucose 4-epimerase inhibitor | 0.114 0.048 DBMET00966 | DBMET00966 | |
| 0.01 | 0.284 | 0.049 | Phosphodiesterase 4C inhibitor | 0.049 0.047 DBMET00954 | DBMET00954 | |
| 0.039 | 0.313 | 0.111 | Alpha-N-acetylglucosaminidase inhibitor | 0.111 0.087 DBMET00966 | DBMET00966 | |
| 0.047 | 0.331 | 0.164 | Diuretic | 0.164 0.066 DBMET00966 0.133 0.091 DBMET00954 | DBMET00966 | |
| 0.054 | 0.347 | 0.156 | Hexokinase inhibitor | 0.156 0.072 DBMET00966 0.13 0.103 DBMET00956 | DBMET00966 | |
| 0.016 | 0.314 | 0.07 | Glutamate decarboxylase inhibitor | 0.07 0.055 DBMET00956 | DBMET00956 | |
| 0.104 | 0.406 | 0.248 | GABA C receptor rho-3 antagonist | 0.206 0.2 DBMET00324 0.22 0.184 DBMET00957 0.248 0.156 DBMET00956 | DBMET00956 | |
| 0.034 | 0.337 | 0.082 | Triose-phosphate isomerase inhibitor | 0.082 0.072 DBMET00966 | DBMET00966 | |
| 0.015 | 0.321 | 0.093 | Porphobilinogen synthase inhibitor | 0.093 0.039 DBMET00956 | DBMET00956 | |
| 0.025 | 0.332 | 0.117 | Somatostatin 1 agonist | 0.077 0.055 DBMET00954 0.117 0.025 DBMET00956 | DBMET00956 | |
| 0.023 | 0.334 | 0.09 | Protein kinase C delta inhibitor | 0.09 0.062 DBMET00954 | DBMET00954 | |
| 0.059 | 0.371 | 0.314 | Tumour necrosis factor alpha release inhibitor | 0.28 0.062 DBMET00966 0.314 0.048 DBMET00954 | DBMET00954 | |
| 0.017 | 0.329 | 0.056 | Lysine-specific demethylase 1A inhibitor | 0.056 0.034 DBMET00954 | DBMET00954 | |
| 0.094 | 0.41 | 0.578 | Antibacterial | 0.578 0.023 DBMET00966 0.279 0.151 DBMET00956 | DBMET00966 | |
| 0.018 | 0.342 | 0.063 | Heparanase inhibitor | 0.063 0.019 DBMET00966 | DBMET00966 | |
| 0.013 | 0.35 | 0.064 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.052 DBMET00956 | DBMET00956 | |
| 0.056 | 0.4 | 0.14 | 3C-like protease (Human coronavirus) inhibitor | 0.14 0.12 DBMET00954 | DBMET00954 | |
| 0.028 | 0.384 | 0.056 | Kallikrein 1 inhibitor | 0.053 0.045 DBMET00954 0.056 0.039 DBMET00956 | DBMET00956 | |
| 0.04 | 0.414 | 0.219 | Platelet antagonist | 0.219 0.089 DBMET00966 | DBMET00966 | |
| 0.004 | 0.386 | 0.036 | Vascular adhesion protein 1 inhibitor | 0.036 0.031 DBMET00954 | DBMET00954 | |
| 0.103 | 0.493 | 0.262 | Ca(v)3.3 blocker | 0.262 0.083 DBMET00954 | DBMET00954 | |
| 0.004 | 0.4 | 0.059 | Factor XI inhibitor | 0.059 0.007 DBMET00954 0.057 0.008 DBMET00956 | DBMET00954 | |
| 0.01 | 0.413 | 0.046 | Mineralocorticoid receptor antagonist | 0.046 0.036 DBMET00954 | DBMET00954 | |
| 0.04 | 0.457 | 0.219 | Hemostatic | 0.219 0.027 DBMET00966 0.166 0.051 DBMET00954 0.14 0.081 DBMET00956 | DBMET00966 | |
| 0.032 | 0.457 | 0.16 | Cell adhesion inhibitor | 0.16 0.041 DBMET00966 | DBMET00966 | |
| 0.04 | 0.47 | 0.176 | Insulin secretagoues | 0.176 0.051 DBMET00966 | DBMET00966 | |
| 0.083 | 0.524 | 0.668 | Cyclophilin D inhibitor | 0.668 0.018 DBMET00966 | DBMET00966 | |
| 0.046 | 0.49 | 0.2 | NOS3 expression enhancer | 0.2 0.041 DBMET00966 | DBMET00966 | |
| 0.088 | 0.544 | 0.366 | Interleukin 2 agonist | 0.366 0.039 DBMET00966 0.203 0.184 DBMET00956 | DBMET00966 | |
| 0.027 | 0.496 | 0.178 | Cell wall synthesis inhibitor | 0.178 0.041 DBMET00966 | DBMET00966 | |
| 0.007 | 0.477 | 0.3 | Selectin antagonist | 0.3 0.005 DBMET00966 | DBMET00966 | |
| 0.016 | 0.499 | 0.072 | Cell adhesion molecule inhibitor | 0.072 0.066 DBMET00966 | DBMET00966 | |
| 0.048 | 0.556 | 0.475 | Hypoglycemic | 0.475 0.018 DBMET00966 | DBMET00966 | |
| 0.018 | 0.56 | 0.164 | Anticoagulant | 0.164 0.069 DBMET00966 0.13 0.1 DBMET00956 | DBMET00966 | |
| 0.017 | 0.56 | 0.217 | Thrombolytic | 0.217 0.044 DBMET00966 | DBMET00966 | |
| 0.008 | 0.579 | 0.061 | Plasminogen activator inhibitor | 0.053 0.045 DBMET00954 0.061 0.039 DBMET00956 | DBMET00956 | |
| 0.004 | 0.575 | 0.044 | Plasma kallikrein inhibitor | 0.044 0.015 DBMET00954 0.041 0.018 DBMET00956 | DBMET00954 | |
| 0.007 | 0.613 | 0.049 | Kallikrein inhibitor | 0.049 0.031 DBMET00954 0.048 0.032 DBMET00956 | DBMET00954 | |
| 0.014 | 0.655 | 0.053 | Factor IXa inhibitor | 0.047 0.041 DBMET00966 0.053 0.034 DBMET00956 | DBMET00956 | |
| 0.03 | 0.719 | 0.284 | Immunomodulator | 0.284 0.091 DBMET00966 | DBMET00966 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |